CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway

[1]  M. Mishaeli,et al.  Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location. , 2017, The oncologist.

[2]  D. Sargent,et al.  Lack of Caudal‐Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer , 2017, Clinical colorectal cancer.

[3]  Seung-Yong Jeong,et al.  Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system , 2017, British Journal of Cancer.

[4]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[5]  Kathleen R. Cho,et al.  BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis , 2017, eLife.

[6]  A. Hartmann,et al.  Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients , 2017, The journal of pathology. Clinical research.

[7]  Debashis Sahoo,et al.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. , 2016, The New England journal of medicine.

[8]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[9]  Myeong Sup Lee,et al.  Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation. , 2015, Carcinogenesis.

[10]  L. Galluzzi,et al.  Erratum: Molecular mechanisms of cell death: Central implication of ATP synthase in mitochondrial permeability transition (Oncogene (2015) 34 (1475-1486 ) DOI: 10.1038/onc.2014.96) , 2015 .

[11]  L. Galluzzi,et al.  Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition , 2015, Oncogene.

[12]  N. Cho,et al.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. , 2015, World journal of gastroenterology.

[13]  I. Zlobec,et al.  A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies , 2014, Journal of visualized experiments : JoVE.

[14]  I. Zlobec,et al.  Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high‐level CpG Island methylator phenotype and mismatch repair‐deficiency , 2014, International journal of cancer.

[15]  L. Galluzzi,et al.  Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition , 2014, Oncogene.

[16]  I. Zlobec,et al.  Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer , 2013, Front. Oncol..

[17]  N. Cho,et al.  Loss of CDX2/CK20 Expression Is Associated With Poorly Differentiated Carcinoma, the CpG Island Methylator Phenotype, and Adverse Prognosis in Microsatellite-unstable Colorectal Cancer , 2013, The American journal of surgical pathology.

[18]  B. Leggett,et al.  The serrated pathway to colorectal carcinoma: current concepts and challenges , 2013, Histopathology.

[19]  Hong Zhang,et al.  Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells , 2013, Experimental and therapeutic medicine.

[20]  Melissa E. Ko,et al.  CDX2 is an amplified lineage-survival oncogene in colorectal cancer , 2012, Proceedings of the National Academy of Sciences.

[21]  I. Zlobec,et al.  Comprehensive analysis of CpG island methylator phenotype (CIMP)‐high, ‐low, and ‐negative colorectal cancers based on protein marker expression and molecular features , 2011, The Journal of pathology.

[22]  J. Herman,et al.  Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract , 2011, International journal of cancer.

[23]  Shuji Ogino,et al.  Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer , 2009, Clinical Cancer Research.

[24]  Florian Diehl,et al.  HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. , 2009, Blood.

[25]  L. Terracciano,et al.  Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status , 2008, Modern Pathology.

[26]  Massimo Loda,et al.  Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway* , 2003, Journal of Biological Chemistry.

[27]  B. Torbett,et al.  Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns* , 2003, Journal of Biological Chemistry.

[28]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[29]  Isabelle Duluc,et al.  Key Role of the Cdx2 Homeobox Gene in Extracellular Matrix–mediated Intestinal Cell Differentiation , 1997, The Journal of cell biology.

[30]  K. Chawengsaksophak,et al.  Homeosis and intestinal tumours in Cdx2 mutant mice , 1997, Nature.

[31]  J. Dagorn,et al.  Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down‐regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis , 1997, International journal of cancer.

[32]  P. Traber,et al.  A homeodomain protein related to caudal regulates intestine-specific gene transcription , 1994, Molecular and cellular biology.